Clinical predictors of recurrent venous thromboembolism (VTE) in cancer patients from a randomized trial of long-term tinzaparin versus warfarin for treatment: the CATCH study - Khorana, A A; Bauersachs, R; Kamphuisen, P W (J Clin Oncol, 2015)
(Suppl 1; 9621):